Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

References

• MosesJWLeonMBPopmaJJSirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryN Engl J Med20033491315132314523139
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGCannonLComparison of a polymer-based paclitaxel- eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trialJAMA20052941215122316160130
   PubMed Web of Science ®Google Scholar
• StoneGWMosesJWEllisSGSafety and efficacy of sirolimus-and paclitaxel-eluting coronary stentsN Engl J Med2007356998100817296824
   PubMed Web of Science ®Google Scholar
• AbbottJDVossMRNakamuraMUnrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic RegistryJ Am Coll Cardiol2007502029203618021868
   PubMedGoogle Scholar
• MarroquinOCSelzerFMulukutlaSRA comparison of baremetal and drug-eluting stents for off-label indicationsN Engl J Med200835834235218216354
   PubMedGoogle Scholar
• KingSB3rdSmithSCJrHirshfeldJWJr2007Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing CommitteeCirculation200811726129518079354
   PubMedGoogle Scholar
• TorgusonRWaksmanROverview of the 2007 Food and Drug Administration Circulatory System Devices Panel Meeting on the Xience V Everolimus-Eluting Coronary StentAm J Cardiol20081021624163019064016
   PubMedGoogle Scholar
• DingNPacettiSDTangFWGadaMRoordaWXIENCE V stent design and rationaleJ Interven Cardiol200922S18S27
   Web of Science ®Google Scholar
• WaksmanRPakalaRBaffourROptimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteriesCardiovasc Revasc Med2006717918416945826
   PubMedGoogle Scholar
• GrubeEBuellesfeldLEverolimus for stent-based intracoronary applicationsRev Cardiovasc Med20045Suppl 2S3S815184828
   PubMedGoogle Scholar
• SchulerWSedraniRCottensSSDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivoTransplantation19976436429233698
   PubMed Web of Science ®Google Scholar
• SerruysPWOngATLPiekJJA randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trialEurointervention20051586519758878
   PubMedGoogle Scholar
• TsuchidaKPiekJJNeumannFJOne-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial)Eurointervention2005126627219758915
   PubMedGoogle Scholar
• BeijkMANeumannFJWiemerMTwo-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)Eurointervention2007320621219758939
   PubMedGoogle Scholar
• SerruysPWRuygrokPNeuznerJA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trialEurointervention2006228629419755303
   PubMedGoogle Scholar
• RuygrokPNDesagaMVan Den BrandenFOne year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II studyEurointervention2007331532019737711
   PubMedGoogle Scholar
• KhattabAARichardtGVerinVDifferentiated analysis of an everolimus- eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trialEurointervention2008356657319608482
   PubMedGoogle Scholar
• ClaessenBEBeijkMALegrandVTwo-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V Everolimus-Eluting Stent in the treatment of patients with de novo native coronary artery lesions: The SPIRIT II TrialCirc Cardiovasc Intervent20092339347
   PubMed Web of Science ®Google Scholar
• StoneGWMideiMNewmanWComparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialJAMA20082991903191318430909
   PubMed Web of Science ®Google Scholar
• StoneGWMideiMNewmanWRandomized comparison of everolimus-eluting and paclitaxel-eluting stents two-year clinical follow-up from the clinical evaluation of the Xience V Everolimus Eluting Coronary Stent System in the treatment of patients with de novo native coronary artery lesions (SPIRIT) III TrialCirculation200911968068619171853
   PubMed Web of Science ®Google Scholar
• OnumaYSerruysPWKukurejaNStoneGWSpiritIIInvestIIIRandomized comparison of everolimus-eluting and paclitaxel-eluting stents: pooled analysis of two-year clinical follow-up from the SPIRIT II and III trialsJ Am Coll Cardiol200953A9A10
   Google Scholar
• GordonPCApplegateRJHermillerJBClinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: The SPIRIT III 4.0 mm RegistryCath Cardiovasc Int Published online 31 Aug 2009. DOI: 1.1002/ccd.22259.
   Google Scholar
• ShimohamaTOtakeHAkoJIVUS Analysis in the SPIRIT III Japan Treated with XIENCE V Everolimus-Eluting Stent Compared to the SPIRIT III US ArmAm J Cardiol2008102138I
   Google Scholar
• NikolskyELanskyAJSudhirKSPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery diseaseAm Heart J2009158520526.e219781409
   PubMed Web of Science ®Google Scholar
• JonerMNakazawaGFinnAVEndothelial cell recovery between comparator polymer-based drug-eluting stentsJ Am Coll Cardiol20085233334218652940
   PubMed Web of Science ®Google Scholar
• OnumaYKukrejaNPiazzaNThe everolimus-eluting stent in real- world patients 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) RegistryJ Am Coll Cardiol20095426927619589442
   PubMed Web of Science ®Google Scholar
• Biondi-ZoccaiGLotrionteMMorettiCPercutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher)Minerva Cardioangiol2008561556518432169
   PubMedGoogle Scholar
• ParkKWYoonJHKimJSEfficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: study design and rationale of a Korean multicenter prospective randomized trialAm Heart J2009157811817.e119376305
   PubMed Web of Science ®Google Scholar